Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Deferred Investment Award Programme notified the Company and the under-mentioned persons on 15 April 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1585.00 pence per Share following the re-investment of the dividend paid to shareholders on 10 April 2014.
Mr J Ford |
58.204 |
Mr S A Hussain |
201.180 |
Ms E Walmsley |
818.038 |
Mrs V A Whyte |
216.964 |
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
15 April 2014